A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Clinical trial NCT06584916 · COMPLETED
Trial details
- NCT number
- NCT06584916
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-13
- Primary completion
- 2025-11-21
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.